These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34735092)

  • 21. Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.
    Shoskes DA; Barazani Y; Fareed K; Sabanegh E
    Int Braz J Urol; 2015; 41(6):1167-71. PubMed ID: 26742976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany.
    Kühn CM; Strasser H; Romming A; Wullich B; Goebell PJ
    Urol Int; 2015; 95(2):153-9. PubMed ID: 25677365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.
    Kava BR
    Curr Urol Rep; 2014 Jul; 15(7):422. PubMed ID: 24832199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
    Santella C; Renoux C; Yin H; Yu OHY; Azoulay L
    Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differing levels of testosterone and the prostate: a physiological interplay.
    Goldenberg SL; Koupparis A; Robinson ME
    Nat Rev Urol; 2011 May; 8(7):365-77. PubMed ID: 21629220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels.
    Zhang X; Zhong Y; Saad F; Haider KS; Haider A; Clendenin AG; Xu X
    Aging Male; 2020 Jun; 23(2):112-118. PubMed ID: 30857458
    [No Abstract]   [Full Text] [Related]  

  • 27. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis.
    Kardoust Parizi M; Abufaraj M; Fajkovic H; Kimura S; Iwata T; D'Andrea D; Karakiewicz PI; Shariat SF
    Urol Oncol; 2019 Oct; 37(10):637-646. PubMed ID: 31296421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy.
    Ahlering TE; My Huynh L; Towe M; See K; Tran J; Osann K; El Khatib FM; Yafi FA
    BJU Int; 2020 Jul; 126(1):91-96. PubMed ID: 32124531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy and prostate cancer.
    Morgentaler A
    Urol Clin North Am; 2007 Nov; 34(4):555-63, vii. PubMed ID: 17983895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.
    Pastuszak AW; Pearlman AM; Lai WS; Godoy G; Sathyamoorthy K; Liu JS; Miles BJ; Lipshultz LI; Khera M
    J Urol; 2013 Aug; 190(2):639-44. PubMed ID: 23395803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Testosterone Replacement Therapy in Hypogonadal Men.
    Leung KM; Alrabeeah K; Carrier S
    Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
    Landau D; Tsakok T; Aylwin S; Hughes S
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Seftel AD
    J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
    [No Abstract]   [Full Text] [Related]  

  • 39. Testosterone replacement therapy after primary treatment for prostate cancer.
    Agarwal PK; Oefelein MG
    J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone replacement therapy following radical prostatectomy.
    Khera M; Grober ED; Najari B; Colen JS; Mohamed O; Lamb DJ; Lipshultz LI
    J Sex Med; 2009 Apr; 6(4):1165-1170. PubMed ID: 19207277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.